Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: EC:3.4.21.73 (urokinase-type plasminogen activator)
 10,685 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

We have studied three fibrin-specific thrombolytic agents in a photochemically-induced, guinea-pig femoral artery model of thrombosis. Tissue-type plasminogen activator (t-PA, 0.3 and 1 mg/kg), single-chain urokinase-type plasminogen activator (scu-PA,5 and 15 mg/kg) and a novel thrombolytic agent, staphylokinase (SAK, 0.3 and 1 mg/kg) were intravenously infused for 30 min after arterial occlusion by a photochemically-induced reaction between rose bengal and light (540 nm). These thrombolytic agents induced thrombolysis in 17-66% of animals and 24 h later, reocclusion occurred in 75-100%. t-PA hardly altered plasma fibrinogen throughout the experimental period. In contrast, scu-PA (15 mg/kg) decreased plasma fibrinogen and alpha 2-antiplasmin levels by 25% and 90% respectively 90 min after beginning the infusion. SAK markedly decreased plasma fibrinogen and alpha 2-antiplasmin levels in dose- and time-dependent manners. These results suggest that this model of thrombosis has a relatively high sensitivity to t-PA, which induced thrombolysis without decreasing fibrinogen and alpha 2-antiplasmin, compared with the other two fibrin-specific thrombolytic agents.
 ...
PMID:A thrombosis model for evaluating thrombolytic agents in the guinea-pig: comparison of t-PA, scu-PA and a novel thrombolytic agent, staphylokinase, on thrombolytic activity. 769 99